(Q37167217)

18 August 2017

1 reference

title

Effects of inflammation on pharmacokinetics/pharmacodynamics: increasing recognition of its contribution to variability in response (English)

1 reference

18 August 2017

0 references

1 reference

1 reference

V D Schmith

1

1 reference

18 August 2017

J F Foss

series ordinal

2

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

Clinical Pharmacology & Therapeutics

18 August 2017

published in

1 reference

18 August 2017

volume

83

1 reference

18 August 2017

issue

6

1 reference

18 August 2017

page(s)

809-811

1 reference

Regulation of drug transporters during infection and inflammation.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.62

7 January 2021

Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.62

7 January 2021

Regulation of drug-metabolizing enzymes and transporters in inflammation

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.62

7 January 2021

Regulation of drug metabolism and disposition during inflammation and infection

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.62

7 January 2021

Inflammation and altered drug clearance in cancer: transcriptional repression of a human CYP3A4 transgene in tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.62

7 January 2021

Emerging evidence of the impact of kidney disease on drug metabolism and transport

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.62

7 January 2021

Cytokine gene polymorphism and progression of renal and cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.62

7 January 2021

Decreased dromotropic response to verapamil despite pronounced increased drug concentration in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.62

7 January 2021

Drug-disease interactions: reduced beta-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.62

7 January 2021

Disease-drug interaction: Reduced response to propranolol despite increased concentration in the rat with inflammation

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.62

7 January 2021

Pravastatin reverses the down-regulating effect of inflammation on beta-adrenergic receptors: a disease-drug interaction between inflammation, pravastatin, and propranolol

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.62

7 January 2021

Cytochrome P450 3A4 activity after surgical stress

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.62

7 January 2021

Plasma levels of TNF-alpha and IL-6 are inversely related to cytochrome P450-dependent drug metabolism in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.62

7 January 2021

Identifiers

DOI

10.1038/CLPT.2008.62

1 reference

18 August 2017

1 reference